Research-only note: GLP-1 / GIP / Glucagon Agonist R is not FDA-approved for therapeutic use
What should I consider when deciding between compounded and brand-name medications from TrimRx
Compounded medications are not FDA approved and carry risks related to inconsistent potency, sterility, and formulation quality
Slow titration (increasing the dose gradually) reduces severity substantially (GI Tolerability Across SURMOUNT 1-4, DOM 2025)
Based on current evidence, the answer is reassuring and increasingly hopeful
For the other five percent, your pharmacy is a phone call away, and SeekPeptides members have access to detailed protocols, formulation guides, and community support to navigate every question that arises along the way